Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Should You Buy Rite Aid Corporation (RAD) Stock? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor

Rite-Aid (RAD) stock stands to make a quick gain if Walgreens' offer is accepted. But what happens if the deal doesn't go through?

Should You Buy General Motors Company (GM) Stock? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor

The market may be shrinking and financing trouble may be looming for General Motors, but GM stock is still cheap and boasts a strong yield.

Should You Buy BP plc (ADR) (BP) Stock? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor

BP stock offers a juicy 7% dividend yield. Is it safe, or will a high cost structure and weak oil prices force BP to cut the dividend?

Should You Buy Amgen, Inc. (AMGN) Stock? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor

Amgen stock is back near all-time highs. Will its biosimilar portfolio power it higher, or will legal disputes hold the stock back?

Should You Buy Chevron Corporation (CVX) Stock? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor

Chevron stock still pays a great dividend. But is that enough to compensate for the CVX's risks? Here's what you need to know.

Load More